| 13 |
Libentech Co., Ltd. was selected for the 2022 SME technology innovation development project.
|
관리자 |
Date22.05.12 |
Hit314 |
| 12 |
Signed an industry-academic cooperation agreement with Chungnam National University Medical Research Center
|
관리자 |
Date22.04.21 |
Hit375 |
| 11 |
[Patent application] Korean patent application for oncolytic virus for colorectal cancer treatment based on LVP-K virus vector containing cancer necrosis factor-related a…
|
관리자 |
Date22.04.06 |
Hit368 |
| 10 |
[Patent application] USA Patent application for oncolytic virus for brain tumor treatment using LVP-K Platform and composition for treatment of glioblastoma (brain tumor)…
|
관리자 |
Date21.12.09 |
Hit376 |
| 9 |
[Patent registration] Korean patent registration for oncolytic virus for brain tumor treatment using LVP-K Platform and composition for treatment of glioblastoma (brain t…
|
관리자 |
Date21.12.01 |
Hit290 |
| 8 |
[Patent registration] Korean patent registration for vaccine composition for prevention of SARS corona virus infection in humans and alleviation of infection symptoms
|
관리자 |
Date21.12.01 |
Hit277 |
| 7 |
[Technology Sharing] Technology sharing site through non-face-to-face video conference with Amgen
|
관리자 |
Date21.11.26 |
Hit264 |
| 6 |
[Patent registration] U.S. patent registration for vaccine composition for preventing SARS corona virus infection in humans and alleviating infection symptoms
|
관리자 |
Date21.11.26 |
Hit225 |
| 5 |
Colorectal cancer cell specific infection "M2-LVP-K1" oncolytic virus for colorectal cancer treatment and composition for treatment of colorectal cancer using t…
|
관리자 |
Date21.11.26 |
Hit246 |
| 4 |
Applied for domestic patent and PCT international patent for vaccine composition for prevention of SARS corona virus infection in humans and alleviation of infection symp…
|
관리자 |
Date21.11.26 |
Hit286 |
